RayOne EMV was developed in collaboration with world renowned surgeon, Professor Graham Barrett, to specifically enhance patient outcomes achieved with monovision.

RayOne EMV uniquely extends a patient’s range of vision with a patented non-diffractive optic profile, enabling the depth of field of many presbyopia-correcting IOLs but with reduced dysphotopsia, short neuroadaptation, reliable outcomes, high patient satisfaction, and improved affordability.

Offered on a superior hydrophilic optic platform through the RayOne fully preloaded two-step injector, RayOne EMV is an IOL solution unlike any other.